(Q71774652)
Statements
Phase II trial of weekly i.v. vinorelbine as a single agent in first-line advanced breast cancer chemotherapy. The Latin-American experience (English)
S Bruno
V L Puerto
E Mickiewicz
R Hegg
L C Texeira
L Gaitan
L Martinez
O Fernandez
J Otero